Scientific article
English

Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland

Published inVaccine, vol. 21, no. 23, p. 3273-3281
Publication date2003
Abstract

To compare projected economic costs and health benefits associated with using pneumococcal conjugate heptavalent vaccine as routine immunisation in healthy children in Switzerland.

Keywords
  • Bacteremia/economics/epidemiology/prevention & control
  • Child, Preschool
  • Cost of Illness
  • Cost-Benefit Analysis
  • Decision Support Techniques
  • Humans
  • Immunization Programs/economics
  • Infant
  • Infant, Newborn
  • Meningitis, Pneumococcal/economics/epidemiology/prevention & control
  • Pneumococcal Infections/economics/epidemiology/prevention & control
  • Pneumococcal Vaccines/economics
  • Pneumonia, Pneumococcal/economics/epidemiology/prevention & control
  • Switzerland/epidemiology
  • Treatment Outcome
Citation (ISO format)
ESS, Silvia M et al. Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland. In: Vaccine, 2003, vol. 21, n° 23, p. 3273–3281. doi: 10.1016/S0264-410X(03)00193-2
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0264-410X
536views
1downloads

Technical informations

Creation03/03/2015 14:38:00
First validation03/03/2015 14:38:00
Update time14/03/2023 23:09:18
Status update14/03/2023 23:09:17
Last indexation30/10/2024 23:51:09
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack